The output of a particular rapid antigen diagnostic test for SARS-CoV-2 provides a qualitative detection of nucleocapsid protein antigens from nasal swabs. This diagnostic tool offers a convenient method for quickly identifying potential infections, often delivering results within 15 minutes. A positive outcome suggests the presence of a current infection, while a negative result indicates the likely absence of detectable viral antigens at the time of testing. It’s important to note that these tests primarily detect active infections.
Rapid antigen testing has become a vital tool in managing the COVID-19 pandemic. The speed and accessibility of these tests enable timely decision-making regarding isolation, treatment, and contact tracing efforts. This rapid identification of potential cases can help to curb transmission rates and inform public health strategies. The development and deployment of these tests significantly enhanced responses to the pandemic by offering a readily available diagnostic option for individuals, healthcare providers, and institutions.